OUR MISSION AND GOALS

The Lupus Study Group is composed of experts in the fields of rheumatology and immunology and basic and clinical science related to systemic and cutaneous lupus erythematosus. Our goals are to:

  • Evaluate all new findings in lupus-related fields and translate the results into new research questions
  • Promote the translation of new information into better care of patients with cutaneous and systemic lupus.

Central to our mission is improved communication and education for all persons involved in lupus research and the clinical care of lupus patients.

Management Guidelines

Up to date Classification and Management Guidelines as recommended by ACR and EULAR.

Read More

LSG Forum

Creating an online discussion platform for physicians and researchers to discuss issues central to better management and understanding of lupus.

Read More

Resources

Providing physicians and PCPs access to slides and poster presentations highlighting the most recent developments in lupus research.

Read More

Patients

The Lupus Study Group welcomes patients and strives to provide educational materials that will help them play an active role in the management of their lupus.

Read More
NEWS + ARTICLES

Highlighting recent findings related to basic and clinical lupus research and care

Post hoc analysis of phase 3 TULIP trials of anifrolumab in active SLE show increase in LLDAS attainment

February 20, 2023
A recent post-hoc analysis of results from the phase 3 trials of anifrolumab (Saphnelo) in active SLE, TULIP-1 (NCT02446912) and...

TYK2 inhibitor Deucravacitinib found superior to apremilast in treating plaque psoriasis

February 16, 2023
Results posted to the Journal of the American Academy of Dermatology have shown that the selective oral tyrosine kinase 2...

Exploratory analysis of BEAT-LUPUS trial to identify biomarkers for B-cell targeted therapies

February 7, 2023
A recent study published in Lancet Rheumatology utilizes machine learning to analyze the results of the BEAT-LUPUS clinical trial with...

Whole blood drug levels do not correlate with QTc intervals in hydroxychloroquine-treated systemic lupus erythematosus patients

January 18, 2023
A recent study of SLE patients being treated with hydroxychloroquine (HCQ) investigates a potential risk of cardiac complications from the...

Anti-CD19 CAR T cell therapy for refractory SLE

October 11, 2022
A recent paper published in Nature Medicine investigates the potential of a novel therapy, CAR T cell treatment, in systemic...

Clinical trial tests Iberdomide in SLE for the first time

September 7, 2022
A paper published in February by Dr. Richard Furie, chief of Rheumatology at Northwell Health, describes the findings of a...

Progress Toward Better Treatment of Lupus – Litifilimab Clinical trial update

September 2, 2022
A new editorial by Dr. Daniel Wallace of Cedars-Sinai Medical Center summarizes the findings and impact of two recent clinical...

Patient-Reported Outcomes in Systemic Lupus Erythematosus. Can Lupus Patients Take the Driver’s Seat in Their Disease Monitoring?

September 1, 2022
A fascinating review from Ioannis Parodis and Paul Studenic examines the disconnect between physicians' assessments and patient experiences in SLE...

P2RY8 variants in lupus patients uncover a role for the receptor in immunological tolerance

August 31, 2022
A study from January 2022 has identified novel and rare variants in the gene for P2RY8, a surface receptor molecule...

Clinical Trial Results

May 10, 2022
Clinical Trial Results Results from all stages of clinical trials indicating success or failure of new therapeutics. AllClinical Trial ResultsClinical...

Basic Research

April 28, 2022
Basic Research Novel findings from the research laboratory highlighting new insights into disease pathogenesis. AllBasic ResearchBasic ResearchP2RY8 variants in lupus...

Clinical Research

April 28, 2022
Clinical Research Patient centric research that provides new understanding of disease manifestations. AllClinical ResearchClinical Research, Clinical Trial ResultsClinical trial tests Iberdomide...

Clinical Care

April 28, 2022
Clinical Care New findings that could have an immediate impact on patient care. AllClinical CareClinical Care, Clinical ResearchEffects of immune-mediated...